Do we need drug therapy to manage mild hypertension in the elderly?

Area of Science:

• Cardiology
• Primary Care Medicine
• Public Health

Background:

• Mild hypertension (grade 1/stage 1) is defined by specific blood pressure ranges (140-159/90-99 mm Hg).
• Patient risk stratification (low, medium, high, very high) is crucial for guiding treatment decisions.
• Risk is determined by comorbidities, target organ damage, and cardiovascular/renal conditions.

Purpose of the Study:

• To summarize current guidelines for managing mild hypertension based on risk stratification.
• To assess the implementation of World Health Organization/International Society of Hypertension (WHO/ISH) guidelines in primary care.
• To analyze treatment patterns for mild hypertension in different risk categories.

Main Methods:

• Review of current hypertension management guidelines.
• Analysis of a primary care survey on hypertension treatment.
• Comparison of prescribed antihypertensive drug prevalence across risk categories.

Main Results:

• Guidelines recommend prompt treatment for very high-risk patients, with strong evidence.
• High-risk patients, particularly those with diabetes, require prompt treatment.
• Low and medium-risk patients are advised non-pharmacological measures, with treatment initiated for persistent elevation, though evidence is indirect.
• A survey revealed low treatment rates: 20% (medium-risk), 33% (high-risk), and 67% (very high-risk) elderly men received antihypertensives.
• Treatment prevalence increased with higher blood pressure within each risk category.

Conclusions:

• Current guidelines provide a risk-based approach to mild hypertension management.
• There appears to be a gap between guideline recommendations and actual treatment practices in primary care, particularly for lower-risk patients.
• Further research may be needed to validate treatment strategies for low and medium-risk mild hypertension.